A1Z

Vadadustat

Created:2017-08-09
Last modified:  2020-06-05
Find related ligands:
Help
Chemical Details
Formal Charge0
Atom Count32
Chiral Atom Count0
Bond Count33
Aromatic Bond Count12
2D diagram of A1Z
Toggle HydrogenToggle Labels
Chemical Component Summary
NameVadadustat
SynonymsGSK128863
Systematic Name (OpenEye OEToolkits)2-[[5-(3-chlorophenyl)-3-oxidanyl-pyridin-2-yl]carbonylamino]ethanoic acid
FormulaC14 H11 Cl N2 O4
Molecular Weight306.701
TypeNON-POLYMER
Chemical Descriptors
TypeProgramVersionDescriptor
SMILESCACTVS3.385OC(=O)CNC(=O)c1ncc(cc1O)c2cccc(Cl)c2
SMILESOpenEye OEToolkits2.0.6c1cc(cc(c1)Cl)c2cc(c(nc2)C(=O)NCC(=O)O)O
Canonical SMILESCACTVS3.385 OC(=O)CNC(=O)c1ncc(cc1O)c2cccc(Cl)c2
Canonical SMILESOpenEye OEToolkits2.0.6 c1cc(cc(c1)Cl)c2cc(c(nc2)C(=O)NCC(=O)O)O
InChIInChI1.03 InChI=1S/C14H11ClN2O4/c15-10-3-1-2-8(4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20)
InChIKeyInChI1.03 JGRXMPYUTJLTKT-UHFFFAOYSA-N
Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank IDDB12255 
NameVadadustat
DescriptionOne of the most common symptoms of advanced renal disease is anemia, caused primarily by the inability of the kidney to respond to anemic conditions with a corresponding increase in [erythropoietin] (EPO) production.[A244165] Treatment of anemia of chronic kidney disease (CKD) has traditionally involved the administration of exogenous erythropoiesis-stimulating agents (ESAs), such as [darbepoetin alfa], to counter the decrease in endogenous EPO production. While efficacious, the overuse of ESAs has been associated with cardiovascular complications, progression of CKD, and increases in overall mortality.[A244165] A relatively new and alternative treatment option for patients with anemia of CKD are small molecule inhibitors of hypoxia-inducible factor prolyl-hydroxylase (HIF-PH). These agents inhibit prolyl-hydroxylase domain oxygen sensors, which essentially mimics hypoxic conditions and activates hypoxia-inducible factor, a transcription factor that serves a multitude of roles, including the stimulation erythropoiesis.[A244165] Vadadustat is an orally administered inhibitor of hypoxia-inducible factor prolyl-hydroxylase (HIF-PH) which is currently approved in Japan[L39610] for the treatment for anemia due to CKD in both dialysis-dependent and non-dialysis dependent adult patients, and is currently awaiting a regulatory decision by the FDA for the same indication. The safety and efficacy of vadadustat have been shown to be non-inferior to darbepoetin alfa in patients with anemia of CKD undergoing dialysis,[A244145,A244155] but it did not meet the prespecified noninferiority criterion for cardiovascular safety in a similar study in patients with non-dialysis-dependent CKD.[A244150]
SynonymsVadadustat
Categories
  • Amino Acids
  • Amino Acids, Peptides, and Proteins
  • Antianemic Preparations
  • Blood and Blood Forming Organs
  • Pyridines
ATC-CodeB03XA08
CAS number1000025-07-9

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
Egl nine homolog 1MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQD...unknowninhibitor
Egl nine homolog 2MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHC...unknowninhibitor
Egl nine homolog 3MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQL...unknowninhibitor
Hypoxia-inducible factor 1-alphaMEGAGGANDKKKISSERRKEKSRDAARSRRSKESEVFYELAHQLPLPHNV...unknownstabilization
Endothelial PAS domain-containing protein 1MTADKEKKRSSSERRKEKSRDAARCRRSKETEVFYELAHELPLPHSVSSH...unknownstabilization
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL3646221
PubChem 23634441
ChEMBL CHEMBL3646221